Work

Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response

Year: 2012

Type: article

Source: Leukemia Research

DOI: 10.1016/j.leukres.2012.02.011

Authors: Ho-Young Yhim, Na-Ri Lee, Eun-Kee Song, Chang-Yeol Yim, So Yeon Jeon, Seunghwan Shin, Jeong-A Kim, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak

Institutions: Jeonbuk National University Hospital, Jeonbuk National University, Catholic University of Korea, Woosuk University

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2037101530

FWCI: 6.747

Cites: 22

Cited by: 60

Related to: 10